These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15236370)

  • 21. Technical Note: evaluation of the uncertainties in (choline + creatine)/citrate ratios measured by proton MR spectroscopic imaging in patients suspicious for prostate cancer.
    Zbýň Š; Krššák M; Memarsadeghi M; Gholami B; Haitel A; Weber M; Helbich TH; Trattnig S; Moser E; Gruber S
    Rofo; 2014 Jul; 186(7):698-702. PubMed ID: 24940925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study.
    Mueller-Lisse UG; Vigneron DB; Hricak H; Swanson MG; Carroll PR; Bessette A; Scheidler J; Srivastava A; Males RG; Cha I; Kurhanewicz J
    Radiology; 2001 Nov; 221(2):380-90. PubMed ID: 11687679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results].
    Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B
    Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T.
    Cunningham CH; Vigneron DB; Marjanska M; Chen AP; Xu D; Hurd RE; Kurhanewicz J; Garwood M; Pauly JM
    Magn Reson Med; 2005 May; 53(5):1033-9. PubMed ID: 15844147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
    Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO
    Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of three-dimensional wavelet encoding spectroscopic imaging: in vivo application and method comparison.
    Young R; Serrai H
    Magn Reson Med; 2009 Jan; 61(1):6-15. PubMed ID: 19097215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
    AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast three-dimensional 1H MR spectroscopic imaging at 7 Tesla using "spectroscopic missing pulse--SSFP".
    Schuster C; Dreher W; Stadler J; Bernarding J; Leibfritz D
    Magn Reson Med; 2008 Nov; 60(5):1243-9. PubMed ID: 18836998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging and MR spectroscopic imaging of prostate cancer.
    Rajesh A; Coakley FV
    Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):557-79, vii. PubMed ID: 15271371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fast three-dimensional proton spectroscopic imaging of the human brain at 3 T by combining spectroscopic missing pulse steady-state free precession and echo planar spectroscopic imaging.
    Dreher W; Erhard P; Leibfritz D
    Magn Reson Med; 2011 Dec; 66(6):1518-25. PubMed ID: 21574181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
    Kirilova A; Damyanovich A; Crook J; Jezioranski J; Wallace K; Pintilie M
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):371-8. PubMed ID: 20421147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [1H magnetic resonance spectroscopy of the prostate].
    Mueller-Lisse UG; Scherr M
    Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations.
    Shukla-Dave A; Hricak H; Eberhardt SC; Olgac S; Muruganandham M; Scardino PT; Reuter VE; Koutcher JA; Zakian KL
    Radiology; 2004 Jun; 231(3):717-24. PubMed ID: 15163811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
    Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
    Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI spectroscopy in screening of prostate cancer.
    Goeb K; Engehausen DG; Krause FS; Hollenbach HP; Niedobitek G; Buettner M; Frangou P; Engelhard K
    Anticancer Res; 2007; 27(1B):687-93. PubMed ID: 17348461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.
    Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A
    PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.
    Yu KK; Scheidler J; Hricak H; Vigneron DB; Zaloudek CJ; Males RG; Nelson SJ; Carroll PR; Kurhanewicz J
    Radiology; 1999 Nov; 213(2):481-8. PubMed ID: 10551230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive estimation of prostate cancer aggressiveness using diffusion-weighted MRI and 3D proton MR spectroscopy at 3.0 T.
    Thörmer G; Otto J; Horn LC; Garnov N; Do M; Franz T; Stolzenburg JU; Moche M; Kahn T; Busse H
    Acta Radiol; 2015 Jan; 56(1):121-8. PubMed ID: 24504488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton spectroscopic imaging of the human prostate at 7 T.
    Klomp DW; Bitz AK; Heerschap A; Scheenen TW
    NMR Biomed; 2009 Jun; 22(5):495-501. PubMed ID: 19170072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.